Perdoceo Education (PRDO) Earnings Date & Reports

Key Takeaways

• Perdoceo Education reported third quarter 2026 revenue of $215.9 million, up 1.9% from $211.87 million in the prior-year period.
• Adjusted earnings per diluted share (EPS) rose 18.5% to $0.77, ahead of consensus estimates.
• Operating income increased 8.1% to $55.1 million, while adjusted operating income grew 8.4% to $66.1 million.
• Total student enrollments climbed 1.6%, led by a 7.5% increase at the American InterContinental University System (AIU System) and a 3.2% gain at the University of St. Augustine for Health Sciences.
• Management issued full-year 2026 adjusted EPS guidance of $3.15 to $3.19, above the prior year's $2.61.
• The company signed a definitive agreement to acquire South University, expected to close as early as April 2027.
• For additional details on this ticker's Major News, Today's Price Move, Price Targets, and Forecast, explore these dedicated pages.
• Explore Trending AI Robots to discover AI-driven trading tools and market ideas.

Earnings Context and Why It Matters

Perdoceo Education Corporation operates a portfolio of postsecondary institutions—Colorado Technical University (CTU), the AIU System, and the University of St. Augustine for Health Sciences—serving working adult and graduate health sciences students. Its third quarter results matter because enrollment trends are the leading indicator of future tuition revenue, and profitability hinges on disciplined cost management alongside marketing and technology investments. The company has now posted multiple consecutive quarters of earnings growth, and this report tested whether that momentum could continue even as CTU laps record prior-year enrollment levels. Investors also watched closely for updates on the planned South University acquisition and forward guidance, both of which carry significant implications for the company's growth trajectory into 2027.

Reported Results

For the third quarter ended September 30, 2026, Perdoceo reported revenue of $215.9 million, a 1.9% increase from $211.87 million a year earlier. Net income was $44.4 million, or $0.70 per diluted share, compared with $39.9 million, or $0.60 per diluted share, in the prior-year quarter. Adjusted EPS—which excludes items such as depreciation, amortization, and merger and acquisition (M&A) related legal fees—rose 18.5% to $0.77, exceeding consensus estimates.

Operating income grew 8.1% to $55.1 million, while adjusted operating income increased 8.4% to $66.1 million. Total student enrollments rose 1.6%, with the AIU System up 7.5% to 10,830 students and operating income up 24.9% to $11.6 million. The University of St. Augustine for Health Sciences posted revenue growth of 9.8% to $41.7 million and adjusted operating income of $11.7 million, up from $7.2 million. CTU enrollments held relatively flat at 31,870 students, reflecting the impact of record graduations and tough comparisons.

For the fourth quarter, management guided to adjusted EPS of $0.68 to $0.72 and adjusted operating income of $56.9 million to $59.9 million. For the full year, the company expects adjusted EPS of $3.15 to $3.19 and adjusted operating income of $260.0 million to $263.0 million.

AI Screener

Tickeron's AI Screener is an AI-powered stock and exchange-traded fund (ETF) discovery tool that helps traders and investors filter the market based on technical patterns, fundamentals, trends, volatility, and AI-driven signals. Users can scan thousands of stocks and ETFs using customizable filters such as industry, market capitalization, technical indicators, price patterns, and performance metrics. The screener is designed to help identify trade ideas, trending stocks, breakout candidates, and market opportunities more efficiently than manual screening. For investors tracking education-sector names like Perdoceo, it offers a structured way to surface comparable opportunities and monitor shifting market conditions. Consider exploring the AI Screener to refine your own research workflow.

Market Reaction and Investor Sentiment

Heading into the report, sentiment around Perdoceo was cautiously optimistic, with the company having beaten consensus EPS estimates in seven of its prior eight quarters. The third quarter print reinforced that track record: adjusted EPS of $0.77 came in above consensus, and full-year guidance of $3.15 to $3.19 in adjusted EPS compared favorably with the roughly $3.13 consensus at the time. The main watchpoints for investors were enrollment durability at CTU, margin expansion at the health sciences segment, and the capital-allocation outlook—including share repurchases, dividends, and the pending South University transaction. The combination of solid enrollment growth, strong cash generation, and accretive acquisition plans framed the results as consistent with the company's long-term growth narrative.

Forward Outlook and Key Factors to Monitor

Looking ahead, investors should monitor several themes tied to this report. First, enrollment trajectories remain the clearest forward indicator. CTU is expected to lap record graduation levels through the second half of 2026 before growth normalizes in 2027, while the AIU System faces calendar-driven enrollment variability in the fourth quarter before an anticipated rebound in early 2027.

Second, the University of St. Augustine for Health Sciences continues to scale, with new program modalities supporting growth; its contribution to adjusted operating income is expected to remain meaningful into 2027. Third, cost discipline and marketing efficiency will be important, as the company reinvests a portion of revenue growth into admissions and student support while also navigating elevated legal expenses at CTU.

Finally, the planned acquisition of South University—expected to close as early as April 2027, with roughly $130 million to $150 million in cash at closing and up to $56 million in earn-out payments tied to EBITDA (earnings before interest, taxes, depreciation, and amortization) thresholds—represents a significant catalyst. Management expects the deal to be immediately accretive to adjusted operating income beginning in 2027. Together, these factors will shape how the company's growth and profitability evolve over the coming quarters.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations